• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Organogenesis Holdings Inc. - Class A (NQ:ORGO)

    1.690 -0.720 (-29.88%)
    Streaming Delayed Price Updated: 1:23 PM EDT, Aug 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Organogenesis Holdings Inc. - Class A

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    What's going on in today's session ↗
    Via Chartmill
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    Top movers in Friday's pre-market session ↗
    Via Chartmill
    News headline image
    Organogenesis Q2 Earnings Call Highlights ↗
    Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year decline in second-quarter revenue as the skin substitute market continued to adjust to coverage and payment changes from the Centers for... 
    Via MarketBeat
    Topics Earnings
    Organogenesis Holdings (NASDAQ:ORGO) Plunges 17% as Q2 Revenue and EPS Miss Estimates ↗
    Via Chartmill
    Organogenesis Holdings Inc (NASDAQ:ORGO) Soars on Stellar Q4 Earnings Beat ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
     
    Via Benzinga
    News headline image
    Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
    From World Street Intelligence
    Via GlobeNewswire
    News headline image
    Organogenesis (ORGO) Q1 2026 Earnings Transcript ↗
    Organogenesis (ORGO) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    News headline image
    Organogenesis Q1 Earnings Call Highlights ↗
    Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year revenue decline in the first quarter of 2026, with executives pointing to significant disruption in the skin substitute market following... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
    CANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting... 
    Via MarketMinute
    News headline image
    Organogenesis (ORGO) Q4 2025 Earnings Transcript ↗
    Organogenesis (ORGO) Q4 2025 Earnings Transcript 
    Via The Motley Fool
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    News headline image
    Unusual volume stocks in Monday's session ↗
    Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. 
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session. 
    Via Chartmill
    News headline image
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    These stocks are gapping in today's session ↗
    The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts
    Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its... 
    Via MarketMinute
    News headline image
    Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO
    From The DJS Law Group
    Via Business Wire
    News headline image
    Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?
    Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors... 
    Via MarketMinute
    Topics Fraud
    News headline image
    Why Is Organogenesis Stock Trading Lower Friday? ↗
    Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for the... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.